AUTHENTICATION HARDWARE, AUTHENTICATION SYSTEM, AND USE MANAGEMENT HARDWARE

Details for Australian Patent Application No. 2003261573 (hide)

Owner KONAMI CORPORATION

Inventors MORI, Shoji

Pub. Number AU-A-2003261573

PCT Number PCT/JP03/11719

PCT Pub. Number WO2004/027631

Priority 2002-356515 09.12.02 JP; 2002-272794 19.09.02 JP

Filing date 12 September 2003

Wipo publication date 8 April 2004

International Classifications

G06F 015/00 Digital computers in general

A63F 009/00 Games not otherwise provided for

H04L 009/32 Arrangements for secret or secure communication - including means for verifying the identity or authority of a user of the system

A63F 013/12 Aspects of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game - involving interaction between a plurality of game devices, e.g. transmission or distribution systems

Event Publications

27 November 2003 Complete Application Filed

  Priority application(s): 2002-356515 09.12.02 JP; 2002-272794 19.09.02 JP

20 May 2004 Application Open to Public Inspection

  Published as AU-A-2003261573

2 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003261574-THE DNA-ANTIBODY AND THE USES THEREOF

2003261572-LACTOBACILLUS CASEI LC2W STRAIN AND ITS USE IN ANTIHYPERTENSIVE ASPECT